Delivery Order SPE2DB20D2014-SPE2DB24FD08M

Award Date 9/19/24
Potential Completion Date 9/20/24
Potential Value $5.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,494.63, is for the delivery of VRAYLAR 1.5 MG CAPSULE 30S, a specialty medication. This is a firm fixed-price delivery order contract with an ultimate completion date of April 11, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
This federal contract award, valued at $8,154.96, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corporation. The contract is for the delivery of 4566358010 - VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of November 7, 2024. Amerisourcebergen Drug Corporation is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
This federal contract award, valued at $5,901.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for 4,565,925,539 units of VRAYLAR 4.5 MG CAPSULE 30S, a prescription medication. It has a firm fixed price and an ultimate completion date of September 25, 2024. This contract is not associated with a set-aside program. Amerisourcebergen Drug Corp's Corporate Office Division holds this contract,...
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order issued to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract, valued at $6,419.20, is for the delivery of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of August 30, 2024 and uses a Firm Fixed Price pricing type. This award is not associated with a set-aside program. Amerisourcebergen Drug Corporation is a major supplier of...
This federal contract award, valued at $7,725.78, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a Delivery Order contract type with a Firm Fixed Price pricing structure. The contract covers the supply of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product, with a completion date of September 22, 2023. The contract was not set aside for any specific business type....
This federal contract award, issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA), was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,625.35 firm fixed-price delivery order is to provide VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of January 21, 2025. Amerisourcebergen holds a $999,999,999 Indefinite...
This federal contract award, valued at $5,690.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4567955751 VRAYLAR 1.5 MG CAPSULE 30S, with a completion date of April 18, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type, and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $15,685.92 firm fixed-price delivery order is for the supply of VRAYLAR 1.5 MG CAPSULE 30S, a prescription medication. The contract has an ultimate completion date of September 3, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of 4564882109 - VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $11,940.21, is a Firm Fixed Price Delivery Order with a completion date of June 12, 2024. Amerisourcebergen, as a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,632.13 firm fixed-price delivery order is for the supply of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of November 21, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FD08M
    Delivery Order

This federal contract award, valued at $5,318.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of VRAYLAR 1.5 MG CAPSULE 30S, a pharmaceutical product. This is a firm-fixed-price delivery order contract with a completion date of September 20, 2024. The contract does not have a set-aside designation.

Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment facilities, veterans' hospitals, and other federal healthcare providers. The company has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) by various defense and civilian agencies, including a significant IDC with the DLA Troop Support Medical valued up to $999,999,999 for delivering a comprehensive range of medical commodities.

Generated 12/19/24, 9:26 AM